
Table of Contents
ToggleIn the fast-paced world of critical care and emergency medicine, every second counts. Because the availability of high-quality, life-saving injectables forms the backbone of any successful intensive care unit, hospitals must prioritize reliable sourcing. Among these essential medications, Sodium Bicarbonate Injection IP 8.4% stands as a cornerstone for managing metabolic acidosis, cardiac arrest, and specific drug toxicities. As a leading Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, J-Bans ICU Care Pvt Ltd proudly bridges the gap between advanced pharmaceutical manufacturing and frontline clinical needs.
Through our specialized brand, SODA-Q, we provide healthcare professionals with the precision and reliability required in high-stakes medical environments. In this detailed guide, we explore the significance of this injectable, its clinical applications, and the reasons why medical institutions prefer J-Bans ICU Care Pvt Ltd as their chosen provider.
Sodium Bicarbonate Injection IP 8.4% is a sterile, non-pyrogenic, hypertonic solution formulated for intravenous administration. Acting as a systemic alkalizing agent, this solution increases plasma bicarbonate levels. Consequently, it effectively buffers excess hydrogen ion concentration and raises blood pH to combat metabolic acidosis.
Each ml of the solution typically contains 84 mg of Sodium Bicarbonate IP in Water for Injection. Furthermore, the “IP” designation signifies strict compliance with the Indian Pharmacopoeia standards, which ensures the highest level of purity and safety for patients.
When clinicians administer the drug, the bicarbonate ions ($HCO_3^-$) react with metabolic acids to form water and carbon dioxide. As a result, this process effectively neutralizes acidity within the extracellular fluid. Such rapid action remains vital in stabilizing the dangerous “acid-base” imbalances that occur during systemic failure. Additionally, as a trusted Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, J-Bans ICU Care Pvt Ltd ensures that every batch of SODA-Q maintains precise osmolarity and pH balance.
Within an ICU setting, metabolic acidosis represents a common yet life-threatening condition. This state occurs when the body produces too much acid or when the kidneys fail to remove enough acid from the system. Consequently, without immediate intervention, this imbalance can lead to multi-organ failure.
J-Bans ICU Care Pvt Ltd understands that modern hospitals require a constant supply from a reliable Sodium Bicarbonate Injection IP 8.4% Manufacturer in India. Therefore, whether treating severe renal disease, managing uncontrolled diabetes (ketoacidosis), or addressing circulatory insufficiency due to shock, doctors rely on Sodium Bicarbonate as the primary line of defense to stabilize a patient’s internal environment.
The clinical versatility of Sodium Bicarbonate makes it an indispensable tool in the medical kit. In particular, J-Bans ICU Care Pvt Ltd manufactures SODA-Q to serve the medical community in several critical ways:
This application serves as the primary indication for the drug. By restoring the bicarbonate buffer system, the injection helps reverse the dangerous drop in blood pH often seen in cases of severe dehydration, shock, and renal failure.
During prolonged cardiac arrest, the body undergoes anaerobic metabolism, which leads to a buildup of lactic acid. While medical teams might not use it as a first-line drug in the initial seconds of CPR, they frequently utilize it in late-stage resuscitation. Specifically, it helps manage pre-existing metabolic acidosis or hyperkalemia.
Healthcare providers use Sodium Bicarbonate to alkalinize the urine. Moreover, this process speeds up the excretion of certain drugs like barbiturates and salicylates (aspirin). Most importantly, it proves life-saving in cases of Tricyclic Antidepressant (TCA) overdose by protecting the heart from toxic effects.
By shifting potassium from the extracellular space into the cells, Sodium Bicarbonate helps lower dangerously high blood potassium levels. Accordingly, this intervention prevents the fatal arrhythmias that high potassium might otherwise cause.
J-Bans ICU Care Pvt Ltd operates as more than just a pharmaceutical company; instead, we act as a dedicated partner in patient recovery. We have built our reputation as a top-tier Sodium Bicarbonate Injection IP 8.4% Manufacturer in India on a foundation of quality, innovation, and ethical practices.
We operate state-of-the-art manufacturing facilities designed to meet global benchmarks. For example, our production lines utilize automated systems to minimize human contact. This ensures that every vial of SODA-Q remains sterile and free from contaminants.
As a premier pharmaceutical firm, we strictly adhere to international and domestic standards, including:
At J-Bans ICU Care Pvt Ltd, we believe that quality is a journey rather than a destination. Consequently, our R&D team continuously works to optimize formulations and packaging to ensure the stability of our products in the diverse Indian climate.
Recognizing that different clinical scenarios require varied dosages, J-Bans ICU Care Pvt Ltd—the leading Sodium Bicarbonate Injection IP 8.4% Manufacturer in India—offers the SODA-Q range in three convenient sizes:
By providing these varied formats, J-Bans ICU Care Pvt Ltd ensures that healthcare providers always have the right tool for the right patient. Thus, this versatility reinforces our position as a premier Sodium Bicarbonate Injection IP 8.4% Manufacturer in India.
Selecting a reliable pharmaceutical partner involves evaluating more than just the purchase price. Instead, successful institutions prioritize trust and consistent performance.
Our quality control team subjects every batch of SODA-Q to rigorous testing for:
Our facility features high-speed filling machines, advanced air filtration (HEPA), and sophisticated lab equipment. Consequently, this robust infrastructure allows us to maintain a high production capacity as a major Sodium Bicarbonate Injection IP 8.4% Manufacturer in India.
The name J-Bans ICU Care Pvt Ltd has become synonymous with ICU essentials. Indeed, we maintain a long-standing history of supplying some of the most prestigious hospitals and government healthcare institutions across the country.
The process of serving as an expert manufacturer involves managing complex chemical and physical controls. In particular, J-Bans ICU Care Pvt Ltd focuses on the following:
Because the 8.4% concentration is hypertonic, technicians must handle it with extreme care to prevent crystallization. To address this, we utilize “Aseptic Filling” techniques to ensure the integrity of the solution from the mixing tank to the final sealed container.
We use medical-grade glass and high-quality stoppers that resist the alkaline nature of the bicarbonate solution. This choice prevents leaching and, consequently, ensures a long shelf life, which is a critical factor for any Sodium Bicarbonate Injection IP 8.4% Manufacturer in India.
We maintain our documentation and batch records with meticulous detail. Such transparency ensures that we can provide full traceability for every single unit of SODA-Q that leaves our warehouse.
The Indian healthcare landscape is evolving rapidly. Due to the increase in multi-specialty hospitals and trauma centers, the demand for critical care injectables has surged. Accordingly, as a proactive Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, J-Bans ICU Care Pvt Ltd constantly scales its operations to meet this growing need.
A manufacturer’s role extends far beyond production; it involves securing a robust supply chain. Therefore, during times of medical crisis or market shortages, we remain a steadfast Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, prioritizing hospital requirements to save lives.
J-Bans ICU Care Pvt Ltd operates a vast PAN-India distribution network. We understand that a life-saving drug like SODA-Q provides no value if it fails to reach the ICU on time.
As a dedicated Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, we remain committed to making critical care affordable and accessible to every corner of the nation.

It is primarily indicated for the treatment of metabolic acidosis, which can occur during cardiac arrest, severe renal disease, or uncontrolled diabetes. Additionally, clinicians use it to alkalinize urine in cases of certain drug toxicities.
SODA-Q primarily treats metabolic acidosis. Conversely, medical teams typically manage respiratory acidosis through ventilation. Always consult a physician for specific clinical guidance.
Since this is a hypertonic 8.4% solution, it must be administered slowly into a large vein to minimize the risk of vein irritation or tissue damage (extravasation). Furthermore, clinicians must monitor the patient’s acid-base status and electrolytes continuously.
Yes, it can be used in children, particularly our SODA-Q 10 format. However, dosage must be carefully calculated based on body weight and the severity of the acid-base imbalance.
As a leading Sodium Bicarbonate Injection IP 8.4% Manufacturer in India, we use state-of-the-art aseptic filling technology and HEPA-filtered environments to ensure complete sterility.
Typically, our products have a shelf life of 24 months from the date of manufacture. However, always refer to the specific expiry date printed on the vial or bottle for the most accurate information.
Store it at room temperature and protect it from light. Furthermore, you should avoid freezing the solution. J-Bans ICU Care Pvt Ltd provides detailed storage instructions on all SODA-Q packaging.
It is generally contraindicated in patients with metabolic or respiratory alkalosis, hypocalcemia, or excessive chloride loss. Doctors must weigh the risks in patients with heart failure or severe edema due to the high sodium content.
Yes, we have a specialized division that handles bulk tenders and supplies for government medical colleges and health departments across India.
Our focus on ICU-specific medications, adherence to WHO-GMP standards, and the proven reliability of the SODA-Q brand establish us as a market leader.
The role of a Sodium Bicarbonate Injection IP 8.4% Manufacturer in India carries immense responsibility. Sodium Bicarbonate is more than just a chemical solution; indeed, it is a vital tool for clinicians fighting for patient survival during the most critical hours.
Through SODA-Q 10, SODA-Q 25, and SODA-Q 100, J-Bans ICU Care Pvt Ltd provides a range of solutions tailored to every medical need. Our commitment to manufacturing excellence, quality control, and widespread availability ensures that when a life hangs in the balance, we provide the support needed.
Are you looking for a reliable, high-quality Sodium Bicarbonate Injection IP 8.4% Manufacturer in India? Look no further than J-Bans ICU Care Pvt Ltd. Therefore, we invite hospitals, distributors, and healthcare professionals to connect with us and experience the quality of SODA-Q.
Contact J-Bans ICU Care Pvt Ltd today to secure your supply of life-saving critical care injectables.